Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph C Loftus

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Scientific Reports|May 4, 2026
Structure-guided identification and biological evaluation of reversible EGFR C797S inhibitorsGlen J Weiss, Joseph C Loftus, David W Mallery, et al.
British Journal of Haematology|August 30, 2002
Many alphaIIbbeta3 autoepitopes in chronic immune thrombocytopenic purpura are localized to alphaIIb between amino acids L1 and Q459Robert McMillan, Lei Wang, Jennifer Lopez-Dee, et al.
Neoplasia (New York, N.Y.)|July 7, 2020
TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistanceZonghui Ding, Jean M Kloss, Serdar Tuncali, et al.
Journal of Medicinal Chemistry|December 19, 2009
Structural conservation in band 4.1, ezrin, radixin, moesin (FERM) domains as a guide to identify inhibitors of the proline-rich tyrosine kinase 2Nathalie Meurice, Lei Wang, Christopher A Lipinski, et al.
Cancer Research|June 17, 2005
Targeted measles virus vector displaying echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regressionLouay K Hallak, Jaime R Merchan, Chris M Storgard, et al.
Journal of Signal Transduction|October 29, 2013
A Novel Interaction between Pyk2 and MAP4K4 Is Integrated with Glioma Cell MigrationJoseph C Loftus, Zhongbo Yang, Jean Kloss, et al.
Gynecologic Oncology|June 16, 2004
Effects of raloxifene hydrochloride on endometrial cancer cells in vitroMichael Hibner, Javier F Magrina, Scott R Lefler, et al.
Journal of Neuro-Oncology|July 24, 2008
Extended survival of Pyk2 or FAK deficient orthotopic glioma xenograftsChristopher A Lipinski, Nhan L Tran, Carole Viso, et al.
Molecular Cancer Therapeutics|June 11, 2009
The Pyk2 FERM domain as a target to inhibit glioma migrationJoseph C Loftus, Zhongbo Yang, Nhan L Tran, et al.
Molecular Cancer Research : MCR|October 1, 2010
TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signalingVincent M Paulino, Zhongbo Yang, Jean Kloss, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Scientific Reports|May 4, 2026
Structure-guided identification and biological evaluation of reversible EGFR C797S inhibitorsGlen J Weiss, Joseph C Loftus, David W Mallery, et al.
British Journal of Haematology|August 30, 2002
Many alphaIIbbeta3 autoepitopes in chronic immune thrombocytopenic purpura are localized to alphaIIb between amino acids L1 and Q459Robert McMillan, Lei Wang, Jennifer Lopez-Dee, et al.
Neoplasia (New York, N.Y.)|July 7, 2020
TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistanceZonghui Ding, Jean M Kloss, Serdar Tuncali, et al.
Journal of Medicinal Chemistry|December 19, 2009
Structural conservation in band 4.1, ezrin, radixin, moesin (FERM) domains as a guide to identify inhibitors of the proline-rich tyrosine kinase 2Nathalie Meurice, Lei Wang, Christopher A Lipinski, et al.
Cancer Research|June 17, 2005
Targeted measles virus vector displaying echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regressionLouay K Hallak, Jaime R Merchan, Chris M Storgard, et al.
Journal of Signal Transduction|October 29, 2013
A Novel Interaction between Pyk2 and MAP4K4 Is Integrated with Glioma Cell MigrationJoseph C Loftus, Zhongbo Yang, Jean Kloss, et al.
Gynecologic Oncology|June 16, 2004
Effects of raloxifene hydrochloride on endometrial cancer cells in vitroMichael Hibner, Javier F Magrina, Scott R Lefler, et al.
Journal of Neuro-Oncology|July 24, 2008
Extended survival of Pyk2 or FAK deficient orthotopic glioma xenograftsChristopher A Lipinski, Nhan L Tran, Carole Viso, et al.
Molecular Cancer Therapeutics|June 11, 2009
The Pyk2 FERM domain as a target to inhibit glioma migrationJoseph C Loftus, Zhongbo Yang, Nhan L Tran, et al.
Molecular Cancer Research : MCR|October 1, 2010
TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signalingVincent M Paulino, Zhongbo Yang, Jean Kloss, et al.
Pageof 5